Assessment of the implementation of risk minimization measures for bosentan: a retrospective study
Adherence to bosentan RMMs relevant to minimizing risk of hepatotoxicity either before starting or throughout therapy was low. Our findings could be used as a baseline for monitoring trends in implementation of RMMs over time or to compare performance of various minimization strategies.
Authors
- Adel Alrwisan (ORCID: https://orcid.org/0000-0002-9422-7390)
- Ahmed H. Abdelazeem (ORCID: https://orcid.org/0000-0002-0599-3393)
- Daji Alyami
Institutions
- Beni-Suef University (EG)
- Saudi Arabian Monetary Authority (SA)
- Riyadh Elm University (SA)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-08-22
- DOI
- https://doi.org/10.1080/14740338.2024.2391497
- Citations
- 1
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.37